中药复方治疗新型冠状病毒肺炎的疗效与潜在机制:实验室与临床研究进展
本文综述了中药复方治疗新型冠状病毒肺炎(COVID-19)的基础研究与临床应用,显示多种中药复方与常规治疗联用可改善症状和结局,机制涉及缓解临床症状、抑制细胞因子风暴和改善器官功能。连花清瘟、疏风解毒、清肺排毒汤等获得实验室与临床证据支持,但尚需随机对照试验和真实世界研究进一步验证疗效与安全性。
要点
- 中药复方与常规治疗联用可改善COVID-19患者症状和结局。
- 药理活性主要与缓解症状、抑制细胞因子风暴、改善器官功能有关。
- 连花清瘟、疏风解毒、清肺排毒汤等获得实验室与临床证据支持。
核心结论
- 多种中药复方与常规治疗联用可改善COVID-19患者症状和结局,但需更高质量研究验证。
研究设计与样本
- 本文为综述,综合评估从基础研究到临床应用的相关文献,未报告具体样本量。
主要发现
- 中药复方改善COVID-19症状和结局的药理活性主要归因于缓解临床症状、抑制细胞因子风暴和改善器官功能。
- 连花清瘟、疏风解毒、清肺排毒汤等中药复方获得实验室与临床研究证据支持用于缓解COVID-19。
- 本文还讨论了从药用植物开发新型抗病毒药物的方向。
关键数值与推荐
- 连花清瘟、疏风解毒、清肺排毒汤等复方在实验室与临床研究中显示对COVID-19的缓解作用。
- 疗效与安全性证据尚需随机对照试验和真实世界研究支持。
临床怎么用
- 在常规治疗基础上可考虑联用有证据支持的中药复方以改善COVID-19症状和结局。
- 应关注中药复方缓解症状、抑制细胞因子风暴和改善器官功能的潜在作用。
- 使用中药复方时需结合现有证据谨慎评估疗效与安全性。
局限性
- 本文为综述,未报告具体研究数量、样本量或定量合并结果。
- 随机对照试验和真实世界研究仍需开展以充分支持中药复方抗击COVID-19的疗效与安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Coronavirus disease 2019 (COVID-19) pandemic is still spread and has made a severe public health threat around the world. To improve disease progression, emerging Chinese herbal compounds were used in clinical practice and some agents have proven beneficial in treating COVID-19. Here, the relevant literature from basic researches to clinical application were identified and comprehensively assessed. A variety of Chinese herbal compounds have been reported to be effective in improving symptoms and outcomes in patients with COVID-19, particularly together with routine treatment strategy. The pharmacological activities were mainly attributed to the relief of clinical symptoms, inhibition of cytokine storm, and improvement of organ function. Besides, the development of novel antiviral drugs from medicinal herbs were further discussed. The updated laboratory and clinical studies provided the evidence of Chinese herbal compounds such as Lianhua Qingwen prescription, Shufeng Jiedu prescription, and Qingfei Paidu Tang for the relief of COVID-19. However, both of the randomized controlled trials and real world researches need to be done for supporting the evidence including the efficacy and safety in fighting COVID-19.
引用
- Xiang MF, Jin CT, Sun LH, et al. Efficacy and potential mechanisms of Chinese herbal compounds in coronavirus disease 2019: advances of laboratory and clinical studies. Chin Med. 2021. PMID: 34861881. doi:10.1186/s13020-021-00542-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。